StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | ALNY Alnylam Pharmaceuticals | $295.63 | -2.10% | — | — | — | — | — | 44 |
| 1 | TEM Tempus AI | $52.80 | +4.62% | — | — | — | — | — | 73 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $44.07 |
| -3.31% |
| — |
| — |
| — |
| — |
| — |
| 64 |
| 3 | GILD Gilead Sciences | $131.10 | -2.48% | — | — | — | — | — | 60 |
| 4 | LLY Eli Lilly | $1082.20 | -2.06% | — | — | — | — | — | 56 |
| 5 | AMGN Amgen | $329.13 | -2.27% | — | — | — | — | — | 51 |
| 6 | MRNA Moderna | $46.06 | -2.39% | — | — | — | — | — | 49 |
| 7 | REGN Regeneron | $600.66 | -2.30% | — | — | — | — | — | 46 |
| 8 | VRTX Vertex Pharma | $438.40 | -2.04% | — | — | — | — | — | 44 |
| 9 | BNTX BioNTech | $91.70 | -4.43% | — | — | — | — | — | 43 |